These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2783883)

  • 1. Epidermal growth factor receptor protein-tyrosine kinase activity in human cell lines established from squamous carcinomas of the head and neck.
    Maxwell SA; Sacks PG; Gutterman JU; Gallick GE
    Cancer Res; 1989 Mar; 49(5):1130-7. PubMed ID: 2783883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient.
    Gross ME; Zorbas MA; Danels YJ; Garcia R; Gallick GE; Olive M; Brattain MG; Boman BM; Yeoman LC
    Cancer Res; 1991 Mar; 51(5):1452-9. PubMed ID: 1847663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP; Shimizu N
    J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression by retinoic acid of epidermal growth factor receptor autophosphorylation and glycosylation in cultured human head and neck squamous carcinoma cells.
    Kim JS; Steck PA; Gallick GE; Lee JS; Blick M; Hong WK; Lotan R
    J Natl Cancer Inst Monogr; 1992; (13):101-10. PubMed ID: 1389683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
    Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
    Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
    Christensen ME
    Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the epidermal growth factor receptor by phosphorylation.
    Bertics PJ; Weber W; Cochet C; Gill GN
    J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the epidermal growth factor receptor associated with cytoskeletons of A431 cells.
    Roy LM; Gittinger CK; Landreth GE
    J Cell Physiol; 1989 Aug; 140(2):295-304. PubMed ID: 2745564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner.
    Bos M; Mendelsohn J; Kim YM; Albanell J; Fry DW; Baselga J
    Clin Cancer Res; 1997 Nov; 3(11):2099-106. PubMed ID: 9815602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors.
    Minke JM; Schuuring E; van den Berghe R; Stolwijk JA; Boonstra J; Cornelisse C; Hilkens J; Misdorp W
    Cancer Res; 1991 Aug; 51(15):4028-37. PubMed ID: 1649697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
    Faaland CA; Laskin JD; Thomas TJ
    Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
    J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
    Liu SM; Carpenter G
    J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
    Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
    Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand-induced protein tyrosine kinase activity in living cells coexpressing intact EGF receptors and receptors with an extensive cytosolic deletion.
    Dou Y; Hoffman P; Hoffman BL; Carlin C
    J Cell Physiol; 1992 Nov; 153(2):402-7. PubMed ID: 1429858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.